Search

Farley J. Abad

Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )

Most Active Art Unit
2181
Art Unit(s)
2181
Total Applications
1076
Issued Applications
864
Pending Applications
101
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4745301 [patent_doc_number] => 20080089903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES' [patent_app_type] => utility [patent_app_number] => 11/837953 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4461 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089903.pdf [firstpage_image] =>[orig_patent_app_number] => 11837953 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/837953
CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES Aug 12, 2007 Abandoned
Array ( [id] => 5271601 [patent_doc_number] => 20090075377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'MOLECULAR INTERACTIONS IN CELLS' [patent_app_type] => utility [patent_app_number] => 11/833848 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 59941 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075377.pdf [firstpage_image] =>[orig_patent_app_number] => 11833848 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/833848
MOLECULAR INTERACTIONS IN CELLS Aug 2, 2007 Abandoned
Array ( [id] => 6070087 [patent_doc_number] => 20110044937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY' [patent_app_type] => utility [patent_app_number] => 12/375361 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14546 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044937.pdf [firstpage_image] =>[orig_patent_app_number] => 12375361 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375361
STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY Jul 26, 2007 Abandoned
Array ( [id] => 4797436 [patent_doc_number] => 20080009022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Immunization of dairy cattle with chimeric gapC protein against streptococcus infection' [patent_app_type] => utility [patent_app_number] => 11/825796 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 18074 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009022.pdf [firstpage_image] =>[orig_patent_app_number] => 11825796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/825796
Immunization of dairy cattle with chimeric gapC protein against streptococcus infection Jul 8, 2007 Abandoned
Array ( [id] => 4964867 [patent_doc_number] => 20080107687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'FELINE VACCINES AGAINST AVIAN INFLUENZA' [patent_app_type] => utility [patent_app_number] => 11/767276 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28740 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107687.pdf [firstpage_image] =>[orig_patent_app_number] => 11767276 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/767276
FELINE VACCINES AGAINST AVIAN INFLUENZA Jun 21, 2007 Abandoned
Array ( [id] => 5392154 [patent_doc_number] => 20090209467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'VIRAL CAPSID PROTEINS AND ANY PEPTIDES OR COMPOSITIONS THEREOF FOR THE TREATMENT OF PATHOLOGIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/305323 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12445 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209467.pdf [firstpage_image] =>[orig_patent_app_number] => 12305323 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305323
Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders Jun 17, 2007 Issued
Array ( [id] => 4797873 [patent_doc_number] => 20080009459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences' [patent_app_type] => utility [patent_app_number] => 11/818873 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14260 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009459.pdf [firstpage_image] =>[orig_patent_app_number] => 11818873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/818873
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences Jun 14, 2007 Abandoned
Array ( [id] => 4657135 [patent_doc_number] => 20080025996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods and Compositions Comprising Polycationic Compounds' [patent_app_type] => utility [patent_app_number] => 11/757007 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6121 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025996.pdf [firstpage_image] =>[orig_patent_app_number] => 11757007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/757007
Methods and Compositions Comprising Polycationic Compounds May 31, 2007 Abandoned
Array ( [id] => 4670397 [patent_doc_number] => 20080045457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Ancestral Hepatitis C virus envelope protein sequence' [patent_app_type] => utility [patent_app_number] => 11/809365 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15831 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045457.pdf [firstpage_image] =>[orig_patent_app_number] => 11809365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/809365
Ancestral Hepatitis C virus envelope protein sequence May 30, 2007 Abandoned
Array ( [id] => 5045600 [patent_doc_number] => 20070264273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/746415 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23818 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264273.pdf [firstpage_image] =>[orig_patent_app_number] => 11746415 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/746415
SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF May 8, 2007 Abandoned
Array ( [id] => 6632718 [patent_doc_number] => 20100173387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/298583 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18222 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173387.pdf [firstpage_image] =>[orig_patent_app_number] => 12298583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/298583
METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR Apr 26, 2007 Abandoned
Array ( [id] => 6302436 [patent_doc_number] => 20100068224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Method for Producing Viral Vaccine and Therapeutic Peptide Antigens' [patent_app_type] => utility [patent_app_number] => 12/297162 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22241 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068224.pdf [firstpage_image] =>[orig_patent_app_number] => 12297162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/297162
Method for Producing Viral Vaccine and Therapeutic Peptide Antigens Apr 23, 2007 Abandoned
Array ( [id] => 174001 [patent_doc_number] => 07659380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Method of isolation and purification of trypsin from pronase protease and use thereof' [patent_app_type] => utility [patent_app_number] => 11/788714 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9420 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659380.pdf [firstpage_image] =>[orig_patent_app_number] => 11788714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/788714
Method of isolation and purification of trypsin from pronase protease and use thereof Apr 19, 2007 Issued
Array ( [id] => 4669373 [patent_doc_number] => 20080044433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Epitopes of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/786414 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15155 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044433.pdf [firstpage_image] =>[orig_patent_app_number] => 11786414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/786414
Epitopes of hepatitis C virus Apr 9, 2007 Abandoned
Array ( [id] => 5199092 [patent_doc_number] => 20070298410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Assay to detect HCV receptor binding' [patent_app_type] => utility [patent_app_number] => 11/784521 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5962 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298410.pdf [firstpage_image] =>[orig_patent_app_number] => 11784521 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/784521
Assay to detect HCV receptor binding Apr 5, 2007 Abandoned
Array ( [id] => 6451006 [patent_doc_number] => 20100280268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/293589 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35410 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280268.pdf [firstpage_image] =>[orig_patent_app_number] => 12293589 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/293589
HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM Apr 5, 2007 Abandoned
Array ( [id] => 4681816 [patent_doc_number] => 20080248042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc' [patent_app_type] => utility [patent_app_number] => 11/783297 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7810 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248042.pdf [firstpage_image] =>[orig_patent_app_number] => 11783297 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/783297
Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc Apr 4, 2007 Abandoned
Array ( [id] => 4803550 [patent_doc_number] => 20080015139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Soluble virus-specific T-cell receptor compositions' [patent_app_type] => utility [patent_app_number] => 11/784277 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4464 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015139.pdf [firstpage_image] =>[orig_patent_app_number] => 11784277 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/784277
Soluble virus-specific T-cell receptor compositions Apr 4, 2007 Abandoned
Array ( [id] => 7511667 [patent_doc_number] => 20110257377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Covalently linked complexes of HIV TAT and ENV PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/225655 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15046 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257377.pdf [firstpage_image] =>[orig_patent_app_number] => 12225655 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225655
Covalently linked complexes of HIV TAT and ENV PROTEINS Mar 26, 2007 Abandoned
Array ( [id] => 4839407 [patent_doc_number] => 20080279892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Recombinant RSV Virus Expression Systems And Vaccines' [patent_app_type] => utility [patent_app_number] => 11/690957 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 34626 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279892.pdf [firstpage_image] =>[orig_patent_app_number] => 11690957 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/690957
Recombinant RSV Virus Expression Systems And Vaccines Mar 25, 2007 Abandoned
Menu